• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.

作者信息

Storb R, Leisenring W, Deeg H J, Anasetti C, Appelbaum F, Bensinger W, Buckner C D, Clift R, Doney K, Hansen J

出版信息

Blood. 1994 May 1;83(9):2749-50.

PMID:8167353
Abstract
摘要

相似文献

1
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.在接受骨髓移植治疗严重再生障碍性贫血的患者中，比较甲氨蝶呤/环孢素与单用甲氨蝶呤预防移植物抗宿主病的随机试验的长期随访。
Blood. 1994 May 1;83(9):2749-50.
2
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Biol Blood Marrow Transplant. 2005 Jul;11(7):567-8. doi: 10.1016/j.bbmt.2005.03.004.
3
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.重型再生障碍性贫血的骨髓移植：单用甲氨蝶呤与甲氨蝶呤联合环孢素预防急性移植物抗宿主病的比较
Blood. 1986 Jul;68(1):119-25.
4
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.环孢素A与短期甲氨蝶呤联用对比环孢素A用于接受来自 HLA 相同同胞的异基因骨髓移植的重型再生障碍性贫血患者预防移植物抗宿主病：一项GITMO/EBMT随机试验的结果
Blood. 2000 Sep 1;96(5):1690-7.
5
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.用甲氨蝶呤/环孢素预防接受环磷酰胺和HLA配型相合骨髓移植治疗的重型再生障碍性贫血患儿的移植物抗宿主病
Blood. 1991 Aug 15;78(4):1144-5.
6
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Transplant Proc. 1987 Feb;19(1 Pt 3):2608-13.
7
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
Br J Haematol. 1989 Aug;72(4):567-72. doi: 10.1111/j.1365-2141.1989.tb04325.x.
8
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.他克莫司/甲氨蝶呤与环孢素/甲氨蝶呤预防非亲缘供者骨髓移植治疗重型再生障碍性贫血移植物抗宿主病的配对分析
Biol Blood Marrow Transplant. 2009 Dec;15(12):1603-8. doi: 10.1016/j.bbmt.2009.08.012. Epub 2009 Oct 4.
9
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia.三项对照试验的长期随访：比较环孢素与甲氨蝶呤在接受白血病骨髓移植患者中预防移植物抗宿主病的效果
Blood. 1992 Jun 1;79(11):3091-2.
10
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.环孢素、甲氨蝶呤和甲基强的松龙与环孢素和甲氨蝶呤预防 HLA 同型同胞供体骨髓移植中移植物抗宿主病的比较：一项前瞻性随机研究。
Blood. 2000 Oct 1;96(7):2391-8.

引用本文的文献

1
Composite tissue transplantation: a rapidly advancing field.复合组织移植：一个快速发展的领域。
Transplant Proc. 2008 Jun;40(5):1237-48. doi: 10.1016/j.transproceed.2008.04.003.